Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,206,858 papers from all fields of science
Search
Sign In
Create Free Account
N 0861
Known as:
9H-Purin-6-amine, N-bicyclo(2.2.1)hept-2-yl-9-methyl-, endo-(+-)-
, N-0861
, N0861
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Adenine
Norbornanes
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Evidence for the presence of A 1 adenosine receptors in the aorta of spontaneously hypertensive rats
M. Fahim
,
Syed Jamal Mustafa
2001
Corpus ID: 25544344
1 Isolated aortic rings (endothelium-intact and -denuded) from spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats were…
Expand
1996
1996
Selective attenuation by N-0861 (N6-endonorboran-2-yl-9-methyladenine) of cardiac A1 adenosine receptor-mediated effects in humans.
Barry D. Bertolet
,
Luiz Belardinelli
,
E. Franco
,
Wilmer W. Nichols
,
R. Kerensky
,
J. A. Hill
Circulation
1996
Corpus ID: 30227806
BACKGROUND To determine the adenosine receptor subtype selectivity of the novel antagonist N-0861, the A1 and A2 receptor…
Expand
Review
1995
Review
1995
Modulation of protein kinase C by adenosine: Involvement of adenosine A1 receptor-pertussis toxin sensitive nucleotide binding protein system
R. Marala
,
Syed Jamal Mustafa
Molecular and Cellular Biochemistry
1995
Corpus ID: 9327029
The objective of this study was to determine whether adenosine A1 or A2 receptor was responsible for the regulation of protein…
Expand
1995
1995
Effect of N-0861, a selective adenosine A1 receptor antagonist, on pharmacologic stress imaging with adenosine.
D. Glover
,
M. Ruiz
,
V. Sansoy
,
R. J. Barrett
,
G. Beller
Journal of Nuclear Medicine
1995
Corpus ID: 25742357
UNLABELLED N6-endonorboman-2-yl-9-methyladenine (N-0861) is a drug which inhibits the A1 adenosine receptor subtype. One proposed…
Expand
1994
1994
Cardiovascular effects of a non-xanthine-selective antagonist of the A1 adenosine receptor in the anaesthetised pig: pharmacological and therapeutic implications.
A. Sidi
,
R. Wesley
,
R. Barrett
,
W. Rush
,
L. Belardinelli
Cardiovascular Research
1994
Corpus ID: 32248924
OBJECTIVE To study antagonism of A1 adenosine receptors in an anaesthetised open chest swine model, the selective A1 receptor…
Expand
1994
1994
Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta.
P. Martin
,
J. May
Journal of Pharmacology and Experimental…
1994
Corpus ID: 36236925
This study was undertaken to characterize the adenosine receptors in the rat vas deferens. Because adenosine receptors have been…
Expand
1994
1994
A selective adenosine A1 receptor antagonist attenuates renal dysfunction during controlled hypotension with adenosine in rats.
R. J. Barrett
,
K. F. Wright
Anesthesia and Analgesia
1994
Corpus ID: 39655490
Adenosine infusion produces sustained, reversible, controlled hypotension in humans, but markedly compromises renal function…
Expand
1993
1993
Effect of selective A1 adenosine receptor antagonism of postdefibrillation cardiovascular depression: evidence for an antiadrenergic role of endogenous adenosine.
R. Wesley
,
D. Porzio
,
M. Sadeghi
Cardiovascular Research
1993
Corpus ID: 25455672
OBJECTIVE The aim was to examine the effect of a selective A1 adenosine receptor antagonist (N-0861) on postdefibrillation…
Expand
1992
1992
Evidence that adenosine receptors in the dog left atrium are not of the typical A1 or A2 adenosine receptor subtypes.
P. Martin
European Journal of Pharmacology
1992
Corpus ID: 4620454
1992
1992
N-0861 selectively antagonizes adenosine A1 receptors in vivo.
R. J. Barrett
,
D. Droppleman
,
K. F. Wright
European Journal of Pharmacology
1992
Corpus ID: 44952935
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE